Farglitazar

This classification denotes an anti-diabetic agent with the molecular formula C34H30N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3433GY7132, chemically known as l-tyrosine, n-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl) but more generally known as farglitazar, which bears US NIH Compound Identifier 170364. The term FARGLITAZAR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations, for tariff and trade purposes, schedule farglitazar under HS 29349990 and SITC 51579. As of Q4 2014, FARGLITAZAR remains US FDA's Preferred Term for this commodity. Farglitazar bears US NLM identifiers UMLS ID C1447907 and NCI Concept Code C81693. SMILES: CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC(C(=O)O)NC4=CC=CC=C4C(=O)C5=CC=CC=C5.